Category: 90806-60-3

Related Products of 90806-60-3, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.90806-60-3, Name is 5-Methoxyisoquinoline-1-carbonitrile, molecular formula is C11H8N2O. In a Article，once mentioned of 90806-60-3

A preliminary communication reported on the pharmacology of the potent partial alpha2-agonist (2-(1,4-benzodioxan-6-ylamino)-2-imidazoline, a 1,4-dioxan derivative of clonidine.Its degree of agonism/antagonism depended upon the peripheral or central alpha2-adrenoreceptor system studied.It was of interest to discover whether a similar substitution of the 1,4-dioxan moiety in other standard alpha-adrenergic agents would similary produce high affinity compounds of complex pharmacological profile.The same substitution when introduced into guanfacine, fenmetazole and tolazoline resulted in unpredictable changes in profile with a reduction in alpha-affinity. – alpha2-adrenoreceptors/antagonism/agonism/clonidine derivatives/1,4-dioxan derivatives

A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. In my other articles, you can also check out more blogs about 90806-60-3

Reference：
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

One of the major reasons for studying chemical kinetics is to use measurements of the macroscopic properties of a system, SDS of cas: 90806-60-3, such as the rate of change in the concentration of reactants or products with time.In a article, mentioned the application of 90806-60-3, Name is 5-Methoxyisoquinoline-1-carbonitrile, molecular formula is C11H8N2O

Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: Identification of the 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent

In the search for AMPA receptor (AMPAR) antagonists, 2,3-benzodiazepines represent a family of specific noncompetitive antagonists with anticonvulsant and neuroprotective properties. We have previously shown that 2,3-benzodiazepin-4-ones possess marked anticonvulsant properties and high affinity for the noncompetitive binding site of the AMPAR complex. In this paper, we report the synthesis and pharmacological characterization of a full set of 2,3-benzodiazepin-4-ones in order to better define the structure-activity relationship (SAR) of this class of compounds. Binding assays and functional tests were performed to evaluate the antagonistic activity at the AMPARs. Through these results we have identified a potent AMPAR antagonist, 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one (5c). This compound noncompetitively inhibited AMPAR-mediated toxicity in primary mouse hippocampal cultures with an IC50 of 1.6 muM and blocked kainate-induced calcium influx in rat cerebellar granule cells with an IC50 of 6.4 muM. Thus, 5c has the in vitro potential as therapeutic drug in the treatment of various neurological disorders.

Sometimes chemists are able to propose two or more mechanisms that are consistent with the available data. SDS of cas: 90806-60-3, If a proposed mechanism predicts the wrong experimental rate law, however, the mechanism must be incorrect.Welcome to check out more blogs about 90806-60-3, in my other articles.

Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem

 

90806-60-3, 5-Methoxyisoquinoline-1-carbonitrile is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated,90806-60-3

Cap-138, step c (0.45 g, 2.44 mmol) was treated with 5N sodium hydroxide solution (10 mL) and the resultingsuspension was heated at 85 C for 4 h, cooled to 25 C, diluted with dichloromethane and acidified with 1N hydrochloricacid. The organic phase was separated, washed with brine, dried over Na2SO4, concentrated to volume and filteredto afford Cap-138 (0.44g, 88.9%) as a yellow solid. 1H NMR (DMSO-d6, 400 MHz) delta 13.6 (br s, 1H), 8.56 (d, J = 6.0 Hz,1H), 8.16 (d, J = 6.0 Hz, 1H), 8.06 (d, J = 8.8 Hz, 1H), 7.71-7.67 (m, 1H), 7.30 (d, J = 8.0 Hz, 1H), 4.02 (s, 3H); Rt = 0.70min (Cond.-D1); 95% homogenity index; LCMS: Anal. Calc. for [M+H]+ C11H10NO3: 204.07; found: 204.05.

As the paragraph descriping shows that 90806-60-3 is playing an increasingly important role.

Reference£º
Patent; Bristol-Myers Squibb Company; BELEMA, Makonen; NGUYEN, Van N.; SERRANO-WU, Michael; ST. LAURENT, Denis R.; QIU, Yuping; DING, Min; MEANWELL, Nicholas A.; SNYDER, Lawrence B.; (149 pag.)EP2328865; (2017); B1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.90806-60-3,5-Methoxyisoquinoline-1-carbonitrile,as a common compound, the synthetic route is as follows.,90806-60-3

Cap- 138, step c (0.45 g, 2.44 mmol) was treated with 5N sodium hydroxide solution (10 mL) and the resulting suspension was heated at 85 C for 4 h, cooled to 25 C, diluted with dichloromethane and acidified with IN hydrochloric acid. The organic phase was separated, washed with brine, dried over Na2S04, concentrated to ? volume and filtered to afford Cap-138 as a yellow solid (0.44g, 88.9%). XH NMR (DMSO-d6, 400 MHz) delta 13.6 (br s, 1H), 8.56 (d, J= 6.0 Hz, 1H), 8.16 (d, J = 6.0 Hz, 1H), 8.06 (d, J= 8.8 Hz, 1H), 7.71-7.67 (m, 1H), 7.30 (d, J= 8.0 Hz, 1H), 4.02 (s, 3H); Rt = 0.70 min (Cond.-Dl); 95% homogenity index; LCMS: Anal. Calc. for [M+H]+ CnH10NO3: 204.07; found: 204.05.

The synthetic route of 90806-60-3 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; BRISTOL-MYERS SQUIBB COMPANY; LAVOIE, Rico; BENDER, John A.; ROMINE, Jeffrey Lee; RUEDIGER, Edward H.; BACHAND, Carol; LOPEZ, Omar D.; CHEN, Qi; BELEMA, Makonen; KADOW, John F.; HAMANN, Lawrence G.; WO2011/60000; (2011); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.90806-60-3,5-Methoxyisoquinoline-1-carbonitrile,as a common compound, the synthetic route is as follows.,90806-60-3

Cap- 138, step c (0.45 g, 2.44 mmol) was treated with 5N sodium hydroxide solution (10 mL) and the resulting suspension was heated at 85 C for 4 h, cooled to 25 C, diluted with dichloromethane and acidified with IN hydrochloric acid. The organic phase was separated, washed with brine, dried over Na2S04, concentrated to ? volume and filtered to afford Cap-138 as a yellow solid (0.44g, 88.9%). XH NMR (DMSO-d6, 400 MHz) delta 13.6 (br s, 1H), 8.56 (d, J= 6.0 Hz, 1H), 8.16 (d, J = 6.0 Hz, 1H), 8.06 (d, J= 8.8 Hz, 1H), 7.71-7.67 (m, 1H), 7.30 (d, J= 8.0 Hz, 1H), 4.02 (s, 3H); Rt = 0.70 min (Cond.-Dl); 95% homogenity index; LCMS: Anal. Calc. for [M+H]+ CnH10NO3: 204.07; found: 204.05.

The synthetic route of 90806-60-3 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; BRISTOL-MYERS SQUIBB COMPANY; LAVOIE, Rico; BENDER, John A.; ROMINE, Jeffrey Lee; RUEDIGER, Edward H.; BACHAND, Carol; LOPEZ, Omar D.; CHEN, Qi; BELEMA, Makonen; KADOW, John F.; HAMANN, Lawrence G.; WO2011/60000; (2011); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem

 

90806-60-3, 5-Methoxyisoquinoline-1-carbonitrile is a isoquinoline compound, ?involved in a variety of chemical synthesis. Rlated chemical reaction is continuously updated,90806-60-3

Cap-138, step c (0.45 g, 2.44 mmol) was treated with 5N sodium hydroxide solution (10 mL) and the resulting suspension was heated to 85 0C for 4 h, cooled to 25 0C, diluted with dichloromethane and acidified with IN hydrochloric acid. The organic phase was separated,169 washed with brine, dried, concentrated to 1A volume and filtered to afford Cap-138 as a yellow solid (0.44 g, 88.9%) . 1H NMR (DMSO-d6, 400 MHz) delta 13.6 (br s, IH), 8.56 (d, J” = 6.0 Hz, IH), 8.16 (d, J = 6.0 Hz, IH), 8.06 (d, J = 8.8 Hz, IH), 7.71-7.67 (m, IH), 7.30 (d, J = 8.0 Hz, IH) , 4.02 {s, 3H) ; Rt = 0.70 min (Cond.-Dl); 95% homogenity index; LCMS: Anal. CaIc. for [M+H] + CnHi0N03 : 204.07; found: 204.05.Synthetic Strategy. Method B (derived from Tetrahedron Letters, 2001, 42, 6707) .

The synthetic route of 90806-60-3 has been constantly updated, and we look forward to future research findings.

Reference£º
Patent; BRISTOL-MYERS SQUIBB COMPANY; LAVOIE, Rico; BENDER, John A.; BACHAND, Carol; RUEDIGER, Edward H.; KADOW, John F.; WO2010/120621; (2010); A1;,
Isoquinoline – Wikipedia
Isoquinoline | C9H7N – PubChem